High Tech Pharm Co

High Tech Pharm Co Debt

The Debt of High Tech Pharm Co (106190.KQ) as of Nov 2, 2026 is 8.00 B KRW. In the previous year, Debt was 16.50 B KRW — a change of -51.50% (lower).

Debt

8.00 BKRW

YoY

-51.50%

Last updated:

In 2024, High Tech Pharm Co's total debt was 8.00 B KRW, a -51.50% change from the 16.50 B KRW total debt recorded in the previous year.

The High Tech Pharm Co Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2017
702.00 M KRW
Jan 1, 2018
7.24 B KRW
Jan 1, 2019
10.82 B KRW
Jan 1, 2020
10.48 B KRW
Jan 1, 2021
15.98 B KRW
Jan 1, 2022
16.42 B KRW
Jan 1, 2023
16.50 B KRW
Jan 1, 2024
8.00 B KRW
The High Tech Pharm Co Debt history
YEARDebtYoY
8.00 BKRW-51.50%
16.50 BKRW+0.46%
16.42 BKRW+2.79%
15.98 BKRW+52.40%
10.48 BKRW-3.06%
10.82 BKRW+49.46%
7.24 BKRW+930.77%
702.00 MKRW+4.15%
674.00 MKRW+4.01%
648.00 MKRW-80.00%
3.24 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

High Tech Pharm Co Stock analysis

What does High Tech Pharm Co do? High Tech Pharm Co., Ltd. generates revenue by manufacturing and selling raw materials specifically for injectable antibiotic products. The company's product portfolio consists of sterile imipenem, sterile cilastatin sodium, sterile blended imipenem and cilastatin sodium, injectable sterile meropenem, injectable sterile panipenem, faropenem, and other related pharmaceutical ingredients. These items are produced for use in the medical sector as active pharmaceutical components. The firm sells these antibiotic pharmaceutical ingredients to both domestic and overseas markets. As a Korea-based entity, it distributes its sterile products to buyers who require raw materials for injectable formulations. The company operates from its headquarters in Chungju, Chungcheongbuk-Do, where it utilizes its workforce to support this manufacturing and distribution model. High Tech Pharm Co is one of the most popular companies on Eulerpool.

Debt Details

Understanding High Tech Pharm Co's Debt Structure

High Tech Pharm Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing High Tech Pharm Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to High Tech Pharm Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in High Tech Pharm Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about High Tech Pharm Co stock

Debt of High Tech Pharm Co is 8.00 B KRW in 2024.

Debt of High Tech Pharm Co changed from 16.50 B KRW to 8.00 B KRW, representing a -51.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt High Tech Pharm Co since 2006 – with annual values, charts, and detailed analysis.

Debt's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's High Tech Pharm Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — High Tech Pharm Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — High Tech Pharm Co